Zhe Wang

Zhe Wang

Auto-generated profile, based on publicly available information

Zhe Wang

School of Water Conservancy and Transportation Zhengzhou University Zhengzhou China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
ZWZhe Wang
Zhe Wang
XWXiaoyu Wang
Xiaoyu Wang
ZWZhen Wang
Zhen Wang
YFYuyi Feng
Yuyi Feng
YJYaqin Jia
Yaqin Jia
YLYong Liu
Yong Liu
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm with an incidence of 10 to 12 per 100 000 people worldwide.1,2 Currently, 5 tyrosine kinase inhibitors (TKIs) targeting the activated BCR-ABL1 oncoprotein have been approved by the US Food and Drug Administration (FDA) for the treatment of patients with CML.

12 December 2025 in Construction and Building Materials
Verified
Journal Article
Closed access
HLHeng Liu
Heng Liu
ZWZhe Wang
Zhe Wang
MWMinghao Wang
Minghao Wang
YZYuanxun Zheng
Yuanxun Zheng

29 July 2025 in ZAMM - Journal of Applied Mathematics and Mechanics / Zeitschrift für Angewandte Mathematik und Mechanik
Verified
Journal Article
Closed access
HLHeng Liu
Heng Liu
MWMinghao Wang
Minghao Wang
ZWZhe Wang
Zhe Wang
YZYuanxun Zheng
Yuanxun Zheng
CLCunxin Luo
Cunxin Luo
CDChaowei Du
Chaowei Du